09:53 AM EST, 12/10/2024 (MT Newswires) -- Ligand Pharmaceuticals ( LGND ) said Tuesday it expects 2025 core adjusted earnings of $6.00 to $6.25 per diluted share.

Analysts polled by FactSet expect $6.03.

The company said revenue for the year is expected to be between $180 million and $200 million.

Analysts surveyed by FactSet expect $183.1 million.

For 2024, the company said it continues to expect core adjusted earnings of between $5.50 and $5.70 on revenue of $160 million to $165 million. Analysts polled by FactSet expect core adjusted earnings of $5.65 on revenue of $163.4 million.

Price: 115.08, Change: -1.27, Percent Change: -1.09